Literature DB >> 17315022

Transcriptional features of multiple myeloma patients with chromosome 1q gain.

S Fabris, D Ronchetti, L Agnelli, L Baldini, F Morabito, S Bicciato, D Basso, K Todoerti, L Lombardi, G Lambertenghi-Deliliers, A Neri.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17315022     DOI： 10.1038/sj.leu.2404616

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  21 in total

Review 1.  The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Authors:  Sarah K Johnson; Christoph J Heuck; Anthony P Albino; Pingping Qu; Qing Zhang; Bart Barlogie; John D Shaughnessy
Journal:  Int J Hematol       Date:  2011-10-15       Impact factor: 2.490

2.  Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value.

Authors:  Gang An; Yan Xu; Lihui Shi; Zhong Shizhen; Shuhui Deng; Zhenqing Xie; Weiwei Sui; Fenghuang Zhan; Lugui Qiu
Journal:  Haematologica       Date:  2013-11-08       Impact factor: 9.941

3.  Sequential model selection-based segmentation to detect DNA copy number variation.

Authors:  Jianhua Hu; Liwen Zhang; Huixia Judy Wang
Journal:  Biometrics       Date:  2016-03-08       Impact factor: 2.571

Review 4.  The molecular characterization and clinical management of multiple myeloma in the post-genome era.

Authors:  Y Zhou; B Barlogie; J D Shaughnessy
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

Review 5.  Risk Stratification in Multiple Myeloma.

Authors:  Melissa Gaik-Ming Ooi; Sanjay de Mel; Wee Joo Chng
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

6.  Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon.

Authors:  Jeffrey R Sawyer; Erming Tian; Edward Thomas; Mark Koller; Colin Stangeby; Gael Sammartino; Linda Goosen; Charles Swanson; Regina L Binz; Bart Barlogie; John Shaughnessy
Journal:  Br J Haematol       Date:  2009-09-09       Impact factor: 6.998

Review 7.  LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.

Authors:  Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Manlio Vinciguerra; Antonella Agodi
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 8.  Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive.

Authors:  Sweta Mishra; Johnathan R Whetstine
Journal:  Mol Cell Biol       Date:  2016-01-11       Impact factor: 4.272

9.  The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma.

Authors:  D Ronchetti; K Todoerti; G Tuana; L Agnelli; L Mosca; M Lionetti; S Fabris; P Colapietro; M Miozzo; M Ferrarini; P Tassone; A Neri
Journal:  Blood Cancer J       Date:  2012-11-23       Impact factor: 11.037

10.  LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.

Authors:  Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Carolina Canto; Nadia La Rosa; Maria Antonietta Cantarella; Giuseppa Spampinato; Aurora Scalisi; Antonella Agodi
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.